share this article!

1 minute ago by Reuters1 minute ago by Reuters1 minute ago by Reuters1 Read On November 26, 2019, a GlaxoSmithKline (GSK) logo is seen at the GSK research centre in Stevenage, United Kingdom. (Reuters) – REUTERS/Peter Nicholls/File Photo GlaxoSmithKline announced plans to build a new life sciences campus within its Stevenage, England, R&D center on Friday, raising 400 million pounds ($552.76 million) through the sale of certain land within the plant. The pharmaceutical company said it plans to hire a private developer later this year and start work on the project in 2022. (1 pound = 0.7236 pound) Pushkala Aripaka in Bengaluru contributed reporting, and Shailesh Kuber edited the piece./nRead More

share this article!